Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment
Abstract Spastin is a microtubule (MT) severing enzyme that regulates several cell functions associated with MT dynamics. A reduction in spastin protein levels is responsible for approximately 40% of cases of Hereditary Spastic Paraplegia (HSP), a neurodegenerative disease. Currently, there is no cu...
Saved in:
Main Authors: | Francesca Sardina, Federica Polverino, Sonia Valentini, Claudia Carsetti, Elisabetta Falvo, Giada Tisci, Silvia Soddu, Fabiola Moretti, Alessandro Paiardini, Cinzia Rinaldo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-025-02333-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis
by: Vishesh Khanna, et al.
Published: (2025-02-01) -
Chrysene alters the expression pattern of HSP70 genes in mandarin fish
by: Yufei Liu, et al.
Published: (2025-01-01) -
Study some two loop contribution to muon anomalous MDM in the N-B-LSSM
by: Xing-Yu Han, et al.
Published: (2025-02-01) -
ENO1/Hsp70 Interaction Domains: In Silico and In Vitro Insight for a Putative Therapeutic Target in Cancer
by: Maria Rita Gulotta, et al.
Published: (2025-01-01) -
Modeling and scientific analysis of pediatric medication evaluation based on MDM-DEA-Malmquist model: construction of health management in pediatrics in developing countries
by: Kaixian Fang, et al.
Published: (2025-02-01)